As of July 2025 REGENXBIO has a market cap of โน36.90 Billion. This makes REGENXBIO the world's 7403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน36.90 B | 17.17% |
2024 | โน31.49 B | -52.09% |
2023 | โน65.73 B | -19.09% |
2022 | โน81.25 B | -21.94% |
2021 | โน104.09 B | -16.27% |
2020 | โน124.32 B | 15.03% |
2019 | โน108.07 B | 2.01% |
2018 | โน105.94 B | 60.23% |
2017 | โน66.12 B | 98.13% |
2016 | โน33.37 B | 14.97% |
2015 | โน29.02 B |
On Jul 29th, 2025 the market cap of REGENXBIO was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โน81.92 B | 122.01% | ๐บ๐ธ USA |